Touting close ties to biotech incubators, Mission BioCapital grabs $275M to help launch startups
Before moving to shiny new offices on their venture dimes, many biotech startups trace their beginnings back to shared laboratory spaces like LabCentral and BioLabs.
As the influx of VC dollars push more seasoned players toward earlier stages of investing, Mission BioCapital — the investment firm behind some of the more prominent incubator facilities — has refueled with another $275 million to place a fresh set of bets.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.